As a final conclusion, the authors summarized that HIF1α and SIRT1 might serve as potential therapeutic targets for ovarian cancer [40], establishing an interesting connection between different pathways of observed disturbances and cancer pathogenesis. This evidence concerns the gene HIF1A and ovarian carcinoma.